Skip to main content
Figure 1 | BMC Pulmonary Medicine

Figure 1

From: Multi tyrosine kinase inhibitor dasatinib as novel cause of severe pre-capillary pulmonary hypertension?

Figure 1

Haemodynamics and prognosis factors of dasatinib-associated PAH. Time courses of haemodynamics (Right ventricular systolic pressure, RVSP and mean pulmonary artery pressure, PAPmean, A) as well as exercise capacity (6MWD), WHO functional class and concentration of NT-proBNP (B) of the Hamburg patient are shown. Dashed horizontal line in (B) represents upper normal limit of NT-proBNP concentration (<197 ng/l). RVSP time courses of all three dasatinib-associated PH cases characterised so far are shown in (C). Vertical dashed line represents time of discontinuation of dasatinib treatment.

Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us